Open AccessAB061. P-32. Multicenter, randomized phase II trial of S-1, leucovorin, oxaliplatin and gemcitabine (SLOG) in chemo-naïve advanced biliary tract cancer: a Taiwan Cooperative Oncology Group study
Author(s) -
JenShi Chen,
LiYuan Bai,
MingHuang Chen,
NaiJung Chiang,
Chiun Hsu,
ShihHung Yang,
YungYeh Su,
YanShen Shan,
LiTzong Chen
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.ab061
Subject(s) - gemcitabine , oxaliplatin , medicine , regimen , cisplatin , deoxycytidine , oncology , phases of clinical research , adverse effect , biliary tract cancer , fluorouracil , randomized controlled trial , gastroenterology , chemotherapy , cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom